Drug delivery for tuberculosis: is inhaled therapy the key to success?-Reference-Cited by-同舟云学术

Drug delivery for tuberculosis: is inhaled therapy the key to success?

Published:2017-10 Issue:10 Volume:8 Page:819-821
ISSN:2041-5990
Container-title:Therapeutic Delivery
language:en
Short-container-title:Therapeutic Delivery

Author:

Traini Daniela¹,Young Paul M¹

Affiliation:

1. Respiratory Technology, Woolcock Institute of Medical Research, Sydney, NSW 2037 & Discipline of Pharmacology, Sydney Medical School, University of Sydney, NSW 2006, Australia

Publisher

Future Science Ltd

Subject

Pharmaceutical Science

Link

http://www.future-science.com/doi/pdf/10.4155/tde-2017-0050

Reference27 articles.

1. WHO. Global tuberculosis report 2016 (2016). www.who.int/tb/publications/global_report/en.

2. Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go?

3. Recent advances towards tuberculosis control: vaccines and biomarkers

4. Tuberculosis drug discovery in the post‐post‐genomic era

5. Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The environmental burden of inhalation;European Journal of Pharmaceutical Sciences;2024-09

2. Micro and nano-carriers-based pulmonary drug delivery system: Their current updates, challenges, and limitations – A review;JCIS Open;2023-12

3. A ready-to-use dry powder formulation based on protamine nanocarriers for pulmonary drug delivery;European Journal of Pharmaceutical Sciences;2023-06

4. A Current Perspective on the Potential of Nanomedicine for Anti-Tuberculosis Therapy;Tropical Medicine and Infectious Disease;2023-02-03

5. Application of PLGA as a Biodegradable and Biocompatible Polymer for Pulmonary Delivery of Drugs;AAPS PharmSciTech;2023-01-18